HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer.

Abstract
Full-term pregnancies are associated with long-term reductions in maternal risk of breast cancer, but the biological determinants of the protection are unknown. Experimental observations suggest that human chorionic gonadotropin (hCG), a major hormone of pregnancy, could play a role in this association. A case-control study (242 cases and 450 controls) nested within the Northern Sweden Maternity Cohort included women who had donated a blood sample during the first trimester of a first full-term pregnancy. Total hCG was determined on Immulite 2000 analyzer. Odds ratios (OR) and 95% confidence intervals (CI) were estimated through conditional logistic regression. Maternal breast cancer risk decreased with increasing hCG (upper tertile OR, 0.67; CI, 0.46-0.99), especially for pregnancies before age 25 (upper tertile OR, 0.41; CI, 0.21-0.80). The association diverged according to age at diagnosis: risk was reduced after age 40 (upper tertile OR, 0.60; CI, 0.39-0.91) and seemed to increase before age 40 (upper tertile OR, 1.78; CI, 0.72-4.38). Risk was reduced among those diagnosed 10 years or longer after blood draw (upper tertile OR, 0.60; CI, 0.40-0.90), but not so among those diagnosed within 10 years (upper tertile OR, 4.33; CI, 0.86-21.7). These observations suggest that the association between pregnancy hCG and subsequent maternal risk of breast cancer is modified by age at diagnosis. Although the hormone seems to be a determinant of the reduced risk around or after age 50, it might not confer protection against, or it could even increase the risk of, cancers diagnosed in the years immediately following pregnancy.
AuthorsPaolo Toniolo, Kjell Grankvist, Marianne Wulff, Tianhui Chen, Robert Johansson, Helena Schock, Per Lenner, Göran Hallmans, Matti Lehtinen, Rudolf Kaaks, Göran Wadell, Anne Zeleniuch-Jacquotte, Eva Lundin, Annekatrin Lukanova
JournalCancer research (Cancer Res) Vol. 70 Issue 17 Pg. 6779-86 (Sep 01 2010) ISSN: 1538-7445 [Electronic] United States
PMID20713523 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Chorionic Gonadotropin
Topics
  • Adolescent
  • Adult
  • Age Factors
  • Breast Neoplasms (blood, prevention & control)
  • Case-Control Studies
  • Chorionic Gonadotropin (blood)
  • Cohort Studies
  • Female
  • Humans
  • Middle Aged
  • Pregnancy
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: